ReviewMaterials today. Bio2025
Application of injectable hydrogels in the central and peripheral nervous system as a unique and flexible platform for neural tissue repair.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechano-immunomodulatory biomaterials: From immune mechanosensing to translational design.Bioactive materials · 2026Review
- Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Sodium Alginate Hydrogel with Zinc Ion Nanoparticles for Synergistic Neuroprotection and Functional Recovery in Spinal Cord Injury.Marine drugs · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The nervous system, comprising the central and peripheral components, is essential for regulating physiological functions. Damage to neural tissue often results in severe motor and sensory deficits, with limited endogenous regenerative capacity posing major challenges for repair. Tissue engineering offers promising strategies for neural regeneration by integrating cells, biomaterial scaffolds, and drug delivery systems. Among biomaterials, injectable hydrogels have attracted significant attention due to their biocompatibility, biodegradability, flexibility, and ability to undergo minimally invasive in situ gelation. These hydrogels serve as versatile carriers for cells and therapeutic agents, enabling precise delivery to hard-to-reach tissues while promoting neural repair. This review highlights recent advances in the design, preparation, and application of injectable hydrogels for neural tissue engineering. We discuss their roles in regenerating the brain, spinal cord, and peripheral nerves, address current challenges, and provide perspectives on future developments. Collectively, injectable hydrogels represent a promising platform for developing next-generation regenerative therapies aimed at restoring both anatomical structure and functional outcomes in neural tissues.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.